EMA on COVID-19: 'Fast-Tracking Does Not Mean Cutting Corners'
Agency Insists Safety And Efficacy Are Paramount
Executive Summary
EMA advises caution on COVID-19 vaccine timelines, but says the outlook is more promising for new treatments.
You may also be interested in...
Coronavirus Update: Big Trials, New Vaccine Platforms, And Fake Chloroquine In Africa
In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national and EU level.
Coronavirus Update: EU Regulator Skeptical On Vaccine This Year, Takeda Prepares Hyperimmune Alliance
EMA leader doesn't share Oxford's optimism, Takeda-led alliance forges ahead with plasma-derived therapy plans, Indian pharma firm Cadila gets into testing kits.
EMA Clarifies Fast-Track Mechanisms For COVID-19 Medicines & Vaccines
From speeding up PIP agreements to starting rolling reviews, the European Medicines Agency has explained how it is accelerating its regulatory procedures for COVID-19 treatments and vaccines.